XML 40 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note E - Consolidation of Variable Interest Entity (Tables)
 12 Months Ended
Dec. 31, 2016
Notes Tables  
Equity Method Investments [Table Text Block]
 
December 31,
2015 Pro Forma
(unaudited)
  
Revenue
      
Sales
 $
9,624,375
  
Cost of products sold
  
3,061,299
  
Gross Profit
  
6,563,076
  
Selling, general and administrative expenses
  
12,781,813
  
Research and development expenses
  
892,255
  
Operating expenses
  
13,674,068
  
Loss from operations
  
(7,110,992
 )
Other expenses
  
(6,845
 )
Interest  income
  
3,846
  
Loss before provision for income tax and equity in net earnings of equity investments
  
(7,113,991
 )
Provision for Income Tax
  
(36,157
 )
Loss before equity in net earnings of equity 
investments
  
(7,150,148
 )
Loss on earnings from China Joint Venture
  
(418,432
 )
Loss in equity investments
  
(418,432
 )
Net loss
  
(7,568,580
 )
Less: Net loss attributable to the 
noncontrolling interests
  
(2,101,056
 )
Net loss attributable to Milestone 
Scientific Inc.
 $
(5,467,524
 )